Iain Dukes is a Venture Partner at OrbiMed, leveraging his senior leadership experience in business development and licensing from Merck, Amgen, and GlaxoSmithKline. A University of Oxford D. Phil. graduate, he actively co-founds and leads biotech companies across oncology, infectious disease, and metabolic disorders.
As Chairman of KaNDy Therapeutics, he guided the womens health company to a successful acquisition by Bayer for an upfront consideration of $425 million.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.